Join
Live feed
·
PRReleasevia Quantisnow
Aurinia Pharmaceuticals Inc logo
Kezar Life Sciences Inc. logo

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right

ByQuantisnow·Wall Street's wire, on your screen.
AUPH· Aurinia Pharmaceuticals IncKZR· Kezar Life Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AUPH (Aurinia Pharmaceuticals Inc), KZR (Kezar Life Sciences Inc.) and more on Quantisnow.